This meeting took place in 2017


Here are the related meetings in 2018:
Tuberculosis: Translating Scientific Findings for Clinical and Public Health Impact (X7)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

New Developments in Our Basic Understanding of Tuberculosis (A5)


Organizer(s) Samuel M. Behar and Valerie Mizrahi
January 14—18, 2017
Fairmont Hotel Vancouver • Vancouver, British Columbia Canada
Discounted Abstract Deadline: Sep 21, 2016
Abstract Deadline: Oct 18, 2016
Scholarship Deadline: Sep 21, 2016
Discounted Registration Deadline: Nov 15, 2016

Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation.

Summary of Meeting:
As a contagious disease, tuberculosis remains endemic in many countries and among vulnerable populations. In these settings, it is a major cause of morbidity and mortality. During the past two decades, there has been a renewed effort to develop vaccines and new antibiotics. However, new discoveries that have transformed our understanding of host susceptibility, immunity and disease pathogenesis have not kept pace with the progress of clinical trials. There is a need for new approaches that can limit the impact of tuberculosis around the world. This symposium will focus on fundamental questions about the host-pathogen interaction, bringing together scientists working on the bacterium and the host in model systems, as well as those trying to address basic questions in human immunology and disease. While answering these questions may not be a prerequisite to clinical progress, an improved mechanistic understanding of the survival and subversion strategies that Mycobacterium tuberculosis employs to evade therapy and host immunity will facilitate development of better strategies to treat and prevent tuberculosis. Specifically, the goals of the meeting are to: 1) Articulate a set of priority questions and goals to guide a basic research agenda for the field; 2) Integrate successful approaches employed by leading scientists in other fields that can address knowledge gaps in immunity to tuberculosis; 3) Highlight new technical advances that make possible more sophisticated human experimental biology including defining the critical questions that need to be answered to expedite clinical advances.

View Meeting Program

Scholarships/Awards

Keystone Symposia Future of Science Fund Scholarship Recipients

Hongwei Su
Tsinghua University, China

Nimi Kiran Vashi
National Institute of Immunology, India

National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients

Jacob J. Baker
Michigan State University, USA

Naomi C. Bull
University of Oxford, UK

Berit Annika Carow
Karolinska Institutet, Sweden

Jeremy Huynh
Washington University in St. Louis, USA

Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation
Funded by Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation

Oludele Emmanuel Adebiyi
University College Hospital, Nigeria

Markos Abebe Alemayehu
Armauer Hansen Research Institute, Ethiopia

Michael Kurubire Anaba
University of The Witwatersrand, South Africa

Chaouki Benabdessalem
Institut Pasteur de Tunis, Tunisia

Dmytro Butov
Kharkiv National Medical University, Ukraine

Rebecca Chukwuanukwu
Nnamdi Azikiwe University, Nigeria

Anna Kathleen Coussens
University of Cape Town, South Africa

Areeya Disratthakit
Medical Genetics Center, Medical Life Science Institute, Thailand

Eyasu Ejeta Duken
Jimma University, Ethiopia

Sanjay Gautam
University of Tasmania, Australia

Pawan Gupta
Institute of Microbial Technology, India

Sagarika Haldar
Translational Health Science and Technology Institute, India

Martin Ositadinma Ifeanyichukwu
Nnamdi Azikiwe University, Nigeria

Mulualem Tadesse Jano
Jimma University, Ethiopia

Rose Wanjiku Kamoni
Jomo Kenyatta University of Agriculture and Technology, Kenya

Elena Anatolevna Khaylu
Armauer Hansen Research Institute, Ethiopia

Jessica Katherine Klazen
Stellenbosch University, South Africa

Hao Li
Tsinghua University, China

Vandana Malhotra
Sri Venkateswara College, University of Delhi, India

Georgetta Kumba Mbayo
Medical Research Council, Gambia

Tumaini J. Nagu
Muhimbili University of Health and Allied Sciences, Tanzania

Anna Longdoh Njunda
University of Buea, Cameroon

Jude-Anthony Nnama Ogbulie
Federal University of Technology, Nigeria

Patrick Orikiriza
Epicentre Mbarara Research Centre, Uganda

Nathella Pavan Kumar
National Institute for Research in Tuberculosis, India

Sadia Shakoor
Aga Khan University, Pakistan

Patience Shumba
KwaZulu Natal Research Institute for Tuberculosis and HIV, South Africa

Atul Vashist
A.I.I.M.S. New Delhi, India

Noemí Yokobori
IMEX-CONICET, Argentina

Fathiah Zakham
Hodeidah University, Yemen

Fabiana Albani Zambuzi
University of São Paulo, Brazil